Global OTC Cough, Cold & Allergy Medicine Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 114
Inquire Before Buying

OTC Cough, Cold & Allergy Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global OTC Cough, Cold & Allergy Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Tablet

- Solution

- Drops

- Capsule

- Granules

- Syrup

- Pills

Segment by Application

- Baby

- Toddler

- Preschool Children

- School-age Children

- Adult

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Sanofi-Aventis

- Johnson & Johnson Service

- Reckitt Benckiser Group

- Novartis AG

- GlaxoSmithKline

- AstraZaneca

- Pfizer Inc.

- Sun Pharmaceutical Industries

- Prestige Brands Holdings

- Procter & Gamble

- Bristol-Myers Squib

- Merck

- Allergen

- Toray Industries

- Beijing Tongrentang

- Essence Pharmaceutical Group

- Jiangxi Heying Pharmaceutical

- Diao Group Chengdu Pharmaceutical

- Shanghai Pharmaceutical

- Harbin Children's Pharmaceutical

- China Resources Sanjiu Pharmaceutical

- Xinjiang Quanan Pharmaceutical

- Jiangsu Huayang Pharmaceutical

- Nanjing Chengong Pharmaceutical

- Beijing Jiulong Pharmaceutical

- Livzon Group

- Sinopharm Group

- CSPC

Global OTC Cough, Cold & Allergy Medicine Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Cough, Cold & Allergy Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Solution
1.2.4 Drops
1.2.5 Capsule
1.2.6 Granules
1.2.7 Syrup
1.2.8 Pills
1.3 Market by Application
1.3.1 Global OTC Cough, Cold & Allergy Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Baby
1.3.3 Toddler
1.3.4 Preschool Children
1.3.5 School-age Children
1.3.6 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Cough, Cold & Allergy Medicine Market Perspective (2017-2028)
2.2 OTC Cough, Cold & Allergy Medicine Growth Trends by Region
2.2.1 OTC Cough, Cold & Allergy Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Cough, Cold & Allergy Medicine Historic Market Size by Region (2017-2022)
2.2.3 OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Region (2023-2028)
2.3 OTC Cough, Cold & Allergy Medicine Market Dynamics
2.3.1 OTC Cough, Cold & Allergy Medicine Industry Trends
2.3.2 OTC Cough, Cold & Allergy Medicine Market Drivers
2.3.3 OTC Cough, Cold & Allergy Medicine Market Challenges
2.3.4 OTC Cough, Cold & Allergy Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Revenue
3.1.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Revenue (2017-2022)
3.1.2 Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Players (2017-2022)
3.2 Global OTC Cough, Cold & Allergy Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Cough, Cold & Allergy Medicine Revenue
3.4 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio
3.4.1 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Cough, Cold & Allergy Medicine Revenue in 2021
3.5 OTC Cough, Cold & Allergy Medicine Key Players Head office and Area Served
3.6 Key Players OTC Cough, Cold & Allergy Medicine Product Solution and Service
3.7 Date of Enter into OTC Cough, Cold & Allergy Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Cough, Cold & Allergy Medicine Breakdown Data by Type
4.1 Global OTC Cough, Cold & Allergy Medicine Historic Market Size by Type (2017-2022)
4.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Type (2023-2028)
5 OTC Cough, Cold & Allergy Medicine Breakdown Data by Application
5.1 Global OTC Cough, Cold & Allergy Medicine Historic Market Size by Application (2017-2022)
5.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Cough, Cold & Allergy Medicine Market Size (2017-2028)
6.2 North America OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022)
6.3 North America OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe OTC Cough, Cold & Allergy Medicine Market Size (2017-2028)
7.2 Europe OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022)
7.3 Europe OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Cough, Cold & Allergy Medicine Market Size (2017-2028)
8.2 Asia-Pacific OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America OTC Cough, Cold & Allergy Medicine Market Size (2017-2028)
9.2 Latin America OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022)
9.3 Latin America OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Cough, Cold & Allergy Medicine Market Size (2017-2028)
10.2 Middle East & Africa OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Detail
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Introduction
11.1.4 Sanofi-Aventis Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.1.5 Sanofi-Aventis Recent Development
11.2 Johnson & Johnson Service
11.2.1 Johnson & Johnson Service Company Detail
11.2.2 Johnson & Johnson Service Business Overview
11.2.3 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Introduction
11.2.4 Johnson & Johnson Service Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.2.5 Johnson & Johnson Service Recent Development
11.3 Reckitt Benckiser Group
11.3.1 Reckitt Benckiser Group Company Detail
11.3.2 Reckitt Benckiser Group Business Overview
11.3.3 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Introduction
11.3.4 Reckitt Benckiser Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.3.5 Reckitt Benckiser Group Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG OTC Cough, Cold & Allergy Medicine Introduction
11.4.4 Novartis AG Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.4.5 Novartis AG Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Introduction
11.5.4 GlaxoSmithKline Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Development
11.6 AstraZaneca
11.6.1 AstraZaneca Company Detail
11.6.2 AstraZaneca Business Overview
11.6.3 AstraZaneca OTC Cough, Cold & Allergy Medicine Introduction
11.6.4 AstraZaneca Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.6.5 AstraZaneca Recent Development
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Detail
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. OTC Cough, Cold & Allergy Medicine Introduction
11.7.4 Pfizer Inc. Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.7.5 Pfizer Inc. Recent Development
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Detail
11.8.2 Sun Pharmaceutical Industries Business Overview
11.8.3 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Introduction
11.8.4 Sun Pharmaceutical Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.8.5 Sun Pharmaceutical Industries Recent Development
11.9 Prestige Brands Holdings
11.9.1 Prestige Brands Holdings Company Detail
11.9.2 Prestige Brands Holdings Business Overview
11.9.3 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Introduction
11.9.4 Prestige Brands Holdings Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.9.5 Prestige Brands Holdings Recent Development
11.10 Procter & Gamble
11.10.1 Procter & Gamble Company Detail
11.10.2 Procter & Gamble Business Overview
11.10.3 Procter & Gamble OTC Cough, Cold & Allergy Medicine Introduction
11.10.4 Procter & Gamble Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.10.5 Procter & Gamble Recent Development
11.11 Bristol-Myers Squib
11.11.1 Bristol-Myers Squib Company Detail
11.11.2 Bristol-Myers Squib Business Overview
11.11.3 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Introduction
11.11.4 Bristol-Myers Squib Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.11.5 Bristol-Myers Squib Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck OTC Cough, Cold & Allergy Medicine Introduction
11.12.4 Merck Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.12.5 Merck Recent Development
11.13 Allergen
11.13.1 Allergen Company Detail
11.13.2 Allergen Business Overview
11.13.3 Allergen OTC Cough, Cold & Allergy Medicine Introduction
11.13.4 Allergen Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.13.5 Allergen Recent Development
11.14 Toray Industries
11.14.1 Toray Industries Company Detail
11.14.2 Toray Industries Business Overview
11.14.3 Toray Industries OTC Cough, Cold & Allergy Medicine Introduction
11.14.4 Toray Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.14.5 Toray Industries Recent Development
11.15 Beijing Tongrentang
11.15.1 Beijing Tongrentang Company Detail
11.15.2 Beijing Tongrentang Business Overview
11.15.3 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Introduction
11.15.4 Beijing Tongrentang Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.15.5 Beijing Tongrentang Recent Development
11.16 Essence Pharmaceutical Group
11.16.1 Essence Pharmaceutical Group Company Detail
11.16.2 Essence Pharmaceutical Group Business Overview
11.16.3 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Introduction
11.16.4 Essence Pharmaceutical Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.16.5 Essence Pharmaceutical Group Recent Development
11.17 Jiangxi Heying Pharmaceutical
11.17.1 Jiangxi Heying Pharmaceutical Company Detail
11.17.2 Jiangxi Heying Pharmaceutical Business Overview
11.17.3 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.17.4 Jiangxi Heying Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.17.5 Jiangxi Heying Pharmaceutical Recent Development
11.18 Diao Group Chengdu Pharmaceutical
11.18.1 Diao Group Chengdu Pharmaceutical Company Detail
11.18.2 Diao Group Chengdu Pharmaceutical Business Overview
11.18.3 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.18.4 Diao Group Chengdu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.18.5 Diao Group Chengdu Pharmaceutical Recent Development
11.19 Shanghai Pharmaceutical
11.19.1 Shanghai Pharmaceutical Company Detail
11.19.2 Shanghai Pharmaceutical Business Overview
11.19.3 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.19.4 Shanghai Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.19.5 Shanghai Pharmaceutical Recent Development
11.20 Harbin Children's Pharmaceutical
11.20.1 Harbin Children's Pharmaceutical Company Detail
11.20.2 Harbin Children's Pharmaceutical Business Overview
11.20.3 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.20.4 Harbin Children's Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.20.5 Harbin Children's Pharmaceutical Recent Development
11.21 China Resources Sanjiu Pharmaceutical
11.21.1 China Resources Sanjiu Pharmaceutical Company Detail
11.21.2 China Resources Sanjiu Pharmaceutical Business Overview
11.21.3 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.21.4 China Resources Sanjiu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.21.5 China Resources Sanjiu Pharmaceutical Recent Development
11.22 Xinjiang Quanan Pharmaceutical
11.22.1 Xinjiang Quanan Pharmaceutical Company Detail
11.22.2 Xinjiang Quanan Pharmaceutical Business Overview
11.22.3 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.22.4 Xinjiang Quanan Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.22.5 Xinjiang Quanan Pharmaceutical Recent Development
11.23 Jiangsu Huayang Pharmaceutical
11.23.1 Jiangsu Huayang Pharmaceutical Company Detail
11.23.2 Jiangsu Huayang Pharmaceutical Business Overview
11.23.3 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.23.4 Jiangsu Huayang Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.23.5 Jiangsu Huayang Pharmaceutical Recent Development
11.24 Nanjing Chengong Pharmaceutical
11.24.1 Nanjing Chengong Pharmaceutical Company Detail
11.24.2 Nanjing Chengong Pharmaceutical Business Overview
11.24.3 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.24.4 Nanjing Chengong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.24.5 Nanjing Chengong Pharmaceutical Recent Development
11.25 Beijing Jiulong Pharmaceutical
11.25.1 Beijing Jiulong Pharmaceutical Company Detail
11.25.2 Beijing Jiulong Pharmaceutical Business Overview
11.25.3 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
11.25.4 Beijing Jiulong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.25.5 Beijing Jiulong Pharmaceutical Recent Development
11.26 Livzon Group
11.26.1 Livzon Group Company Detail
11.26.2 Livzon Group Business Overview
11.26.3 Livzon Group OTC Cough, Cold & Allergy Medicine Introduction
11.26.4 Livzon Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.26.5 Livzon Group Recent Development
11.27 Sinopharm Group
11.27.1 Sinopharm Group Company Detail
11.27.2 Sinopharm Group Business Overview
11.27.3 Sinopharm Group OTC Cough, Cold & Allergy Medicine Introduction
11.27.4 Sinopharm Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.27.5 Sinopharm Group Recent Development
11.28 CSPC
11.28.1 CSPC Company Detail
11.28.2 CSPC Business Overview
11.28.3 CSPC OTC Cough, Cold & Allergy Medicine Introduction
11.28.4 CSPC Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022)
11.28.5 CSPC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global OTC Cough, Cold & Allergy Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tablet
Table 3. Key Players of Solution
Table 4. Key Players of Drops
Table 5. Key Players of Capsule
Table 6. Key Players of Granules
Table 7. Key Players of Syrup
Table 8. Key Players of Pills
Table 9. Global OTC Cough, Cold & Allergy Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global OTC Cough, Cold & Allergy Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global OTC Cough, Cold & Allergy Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global OTC Cough, Cold & Allergy Medicine Market Share by Region (2017-2022)
Table 13. Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global OTC Cough, Cold & Allergy Medicine Market Share by Region (2023-2028)
Table 15. OTC Cough, Cold & Allergy Medicine Market Trends
Table 16. OTC Cough, Cold & Allergy Medicine Market Drivers
Table 17. OTC Cough, Cold & Allergy Medicine Market Challenges
Table 18. OTC Cough, Cold & Allergy Medicine Market Restraints
Table 19. Global OTC Cough, Cold & Allergy Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global OTC Cough, Cold & Allergy Medicine Market Share by Players (2017-2022)
Table 21. Global Top OTC Cough, Cold & Allergy Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Cough, Cold & Allergy Medicine as of 2021)
Table 22. Ranking of Global Top OTC Cough, Cold & Allergy Medicine Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by OTC Cough, Cold & Allergy Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players OTC Cough, Cold & Allergy Medicine Product Solution and Service
Table 26. Date of Enter into OTC Cough, Cold & Allergy Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Cough, Cold & Allergy Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Type (2017-2022)
Table 30. Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Type (2023-2028)
Table 32. Global OTC Cough, Cold & Allergy Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Application (2017-2022)
Table 34. Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Application (2023-2028)
Table 36. North America OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific OTC Cough, Cold & Allergy Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific OTC Cough, Cold & Allergy Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa OTC Cough, Cold & Allergy Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa OTC Cough, Cold & Allergy Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 46. Sanofi-Aventis Company Detail
Table 47. Sanofi-Aventis Business Overview
Table 48. Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Product
Table 49. Sanofi-Aventis Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 50. Sanofi-Aventis Recent Development
Table 51. Johnson & Johnson Service Company Detail
Table 52. Johnson & Johnson Service Business Overview
Table 53. Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Product
Table 54. Johnson & Johnson Service Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 55. Johnson & Johnson Service Recent Development
Table 56. Reckitt Benckiser Group Company Detail
Table 57. Reckitt Benckiser Group Business Overview
Table 58. Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Product
Table 59. Reckitt Benckiser Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 60. Reckitt Benckiser Group Recent Development
Table 61. Novartis AG Company Detail
Table 62. Novartis AG Business Overview
Table 63. Novartis AG OTC Cough, Cold & Allergy Medicine Product
Table 64. Novartis AG Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Product
Table 69. GlaxoSmithKline Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. AstraZaneca Company Detail
Table 72. AstraZaneca Business Overview
Table 73. AstraZaneca OTC Cough, Cold & Allergy Medicine Product
Table 74. AstraZaneca Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 75. AstraZaneca Recent Development
Table 76. Pfizer Inc. Company Detail
Table 77. Pfizer Inc. Business Overview
Table 78. Pfizer Inc. OTC Cough, Cold & Allergy Medicine Product
Table 79. Pfizer Inc. Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 80. Pfizer Inc. Recent Development
Table 81. Sun Pharmaceutical Industries Company Detail
Table 82. Sun Pharmaceutical Industries Business Overview
Table 83. Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Product
Table 84. Sun Pharmaceutical Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 85. Sun Pharmaceutical Industries Recent Development
Table 86. Prestige Brands Holdings Company Detail
Table 87. Prestige Brands Holdings Business Overview
Table 88. Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Product
Table 89. Prestige Brands Holdings Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 90. Prestige Brands Holdings Recent Development
Table 91. Procter & Gamble Company Detail
Table 92. Procter & Gamble Business Overview
Table 93. Procter & Gamble OTC Cough, Cold & Allergy Medicine Product
Table 94. Procter & Gamble Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 95. Procter & Gamble Recent Development
Table 96. Bristol-Myers Squib Company Detail
Table 97. Bristol-Myers Squib Business Overview
Table 98. Bristol-Myers Squib OTC Cough, Cold & Allergy MedicineProduct
Table 99. Bristol-Myers Squib Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 100. Bristol-Myers Squib Recent Development
Table 101. Merck Company Detail
Table 102. Merck Business Overview
Table 103. Merck OTC Cough, Cold & Allergy MedicineProduct
Table 104. Merck Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Allergen Company Detail
Table 107. Allergen Business Overview
Table 108. Allergen OTC Cough, Cold & Allergy MedicineProduct
Table 109. Allergen Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 110. Allergen Recent Development
Table 111. Toray Industries Company Detail
Table 112. Toray Industries Business Overview
Table 113. Toray Industries OTC Cough, Cold & Allergy MedicineProduct
Table 114. Toray Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 115. Toray Industries Recent Development
Table 116. Beijing Tongrentang Company Detail
Table 117. Beijing Tongrentang Business Overview
Table 118. Beijing Tongrentang OTC Cough, Cold & Allergy MedicineProduct
Table 119. Beijing Tongrentang Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 120. Beijing Tongrentang Recent Development
Table 121. Essence Pharmaceutical Group Company Detail
Table 122. Essence Pharmaceutical Group Business Overview
Table 123. Essence Pharmaceutical Group OTC Cough, Cold & Allergy MedicineProduct
Table 124. Essence Pharmaceutical Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 125. Essence Pharmaceutical Group Recent Development
Table 126. Jiangxi Heying Pharmaceutical Company Detail
Table 127. Jiangxi Heying Pharmaceutical Business Overview
Table 128. Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 129. Jiangxi Heying Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 130. Jiangxi Heying Pharmaceutical Recent Development
Table 131. Diao Group Chengdu Pharmaceutical Company Detail
Table 132. Diao Group Chengdu Pharmaceutical Business Overview
Table 133. Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 134. Diao Group Chengdu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 135. Diao Group Chengdu Pharmaceutical Recent Development
Table 136. Shanghai Pharmaceutical Company Detail
Table 137. Shanghai Pharmaceutical Business Overview
Table 138. Shanghai Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 139. Shanghai Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 140. Shanghai Pharmaceutical Recent Development
Table 141. Harbin Children's Pharmaceutical Company Detail
Table 142. Harbin Children's Pharmaceutical Business Overview
Table 143. Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 144. Harbin Children's Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 145. Harbin Children's Pharmaceutical Recent Development
Table 146. China Resources Sanjiu Pharmaceutical Company Detail
Table 147. China Resources Sanjiu Pharmaceutical Business Overview
Table 148. China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 149. China Resources Sanjiu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 150. China Resources Sanjiu Pharmaceutical Recent Development
Table 151. Xinjiang Quanan Pharmaceutical Company Detail
Table 152. Xinjiang Quanan Pharmaceutical Business Overview
Table 153. Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 154. Xinjiang Quanan Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 155. Xinjiang Quanan Pharmaceutical Recent Development
Table 156. Jiangsu Huayang Pharmaceutical Company Detail
Table 157. Jiangsu Huayang Pharmaceutical Business Overview
Table 158. Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 159. Jiangsu Huayang Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 160. Jiangsu Huayang Pharmaceutical Recent Development
Table 161. Nanjing Chengong Pharmaceutical Company Detail
Table 162. Nanjing Chengong Pharmaceutical Business Overview
Table 163. Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 164. Nanjing Chengong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 165. Nanjing Chengong Pharmaceutical Recent Development
Table 166. Beijing Jiulong Pharmaceutical Company Detail
Table 167. Beijing Jiulong Pharmaceutical Business Overview
Table 168. Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy MedicineProduct
Table 169. Beijing Jiulong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 170. Beijing Jiulong Pharmaceutical Recent Development
Table 171. Livzon Group Company Detail
Table 172. Livzon Group Business Overview
Table 173. Livzon Group OTC Cough, Cold & Allergy MedicineProduct
Table 174. Livzon Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 175. Livzon Group Recent Development
Table 176. Sinopharm Group Company Detail
Table 177. Sinopharm Group Business Overview
Table 178. Sinopharm Group OTC Cough, Cold & Allergy MedicineProduct
Table 179. Sinopharm Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 180. Sinopharm Group Recent Development
Table 181. CSPC Company Detail
Table 182. CSPC Business Overview
Table 183. CSPC OTC Cough, Cold & Allergy MedicineProduct
Table 184. CSPC Revenue in OTC Cough, Cold & Allergy Medicine Business (2017-2022) & (US$ Million)
Table 185. CSPC Recent Development
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Cough, Cold & Allergy Medicine Market Share by Type: 2021 VS 2028
Figure 2. Tablet Features
Figure 3. Solution Features
Figure 4. Drops Features
Figure 5. Capsule Features
Figure 6. Granules Features
Figure 7. Syrup Features
Figure 8. Pills Features
Figure 9. Global OTC Cough, Cold & Allergy Medicine Market Share by Application in 2021 & 2028
Figure 10. Baby Case Studies
Figure 11. Toddler Case Studies
Figure 12. Preschool Children Case Studies
Figure 13. School-age Children Case Studies
Figure 14. Adult Case Studies
Figure 15. OTC Cough, Cold & Allergy Medicine Report Years Considered
Figure 16. Global OTC Cough, Cold & Allergy Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global OTC Cough, Cold & Allergy Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global OTC Cough, Cold & Allergy Medicine Market Share by Region: 2021 VS 2028
Figure 19. Global OTC Cough, Cold & Allergy Medicine Market Share by Players in 2021
Figure 20. Global Top OTC Cough, Cold & Allergy Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Cough, Cold & Allergy Medicine as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by OTC Cough, Cold & Allergy Medicine Revenue in 2021
Figure 22. North America OTC Cough, Cold & Allergy Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America OTC Cough, Cold & Allergy Medicine Market Share by Country (2017-2028)
Figure 24. United States OTC Cough, Cold & Allergy Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada OTC Cough, Cold & Allergy Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe OTC Cough, Cold & Allergy Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe OTC Cough, Cold & Allergy Medicine Market Share by Country (2017-2028)
Figure 28. Germany OTC Cough, Cold & Allergy Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France OTC
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs